ZrOILHZyNAoJy97ImgzU

(CACI, ATHX, ORN) CRWENewswire Stocks to Watch

  • 0
  • 0

Athersys Inc - ATHX - reported positive results from its Phase I clinical trial of MultiStem, its cell therapy product, administered to individuals undergoing allogeneic hematopoietic stem cell transplants for the treatment of leukemia and related conditions.

02 Feb 2012

122 Visualizações

athx, caci, orn

Estatísticas do vídeo

Mostrar:

Comentários

Vídeos em Destaque